# Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

> **NCT03002519** · PHASE1 · COMPLETED · sponsor: **Pluristem Ltd.** · enrollment: 21 (actual)

## Conditions studied

- Incomplete HCT (Hematopoietic Cell Transplantation)

## Interventions

- **BIOLOGICAL:** PLX-R18

## Key facts

- **NCT ID:** NCT03002519
- **Lead sponsor:** Pluristem Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-08
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-10-30
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03002519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03002519, "Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03002519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*